Skip to main content
Premium Trial:

Request an Annual Quote

Meet the Moonshot Experts

ScienceInsider's Jocelyn Kaiser reports that the National Cancer Institute has named a "blue ribbon panel" of 28 experts to help Vice President Joe Biden's cancer moonshot program realize its goals.

The panel is a working group of the NCI's National Cancer Advisory Board, and will have three co-chairs: MIT cancer biologist Tyler Jacks, Johns Hopkins cancer immunologist Elizabeth Jaffee, and NCI Acting Deputy Director Dinah Singer, says Kaiser, adding that "the other panelists include cancer center directors, researchers in tumor genomics and cancer immunotherapy, patient advocates, and industry leaders, including Patrick Soon-Shiong, CEO of NantWorks, who recently launched his own cancer moonshot to test immunotherapy drugs."

The advisory board plans to hold a meeting in the spring to discuss how academia and industry can collaborate. It will also take ideas from the public, and will then pass its ideas to the NCI advisory board, which plans to release a tentative research plan by late summer, Kaiser adds. The White House Cancer Moonshot Task Force will then deliver a report to President Obama by the end of the year.

Filed under

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.